Profile data is unavailable for this security.
About the company
Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.
- Revenue in USD (TTM)1.85bn
- Net income in USD372.21m
- Incorporated1997
- Employees8.72k
- LocationAlign Technology Inc2820 Orchard PkwySAN JOSE 95134-2019United StatesUSA
- Phone+1 (408) 470-1000
- Fax+1 (408) 470-1010
- Websitehttp://www.aligntech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steris PLC | 2.70bn | 296.91m | 9.78bn | 12.00k | 33.35 | 3.14 | 20.38 | 3.63 | 3.47 | 3.69 | 31.50 | 36.90 | 0.5316 | 6.89 | 5.73 | 224,632.70 | 5.87 | 4.28 | 6.35 | 4.73 | 41.74 | 40.56 | 11.05 | 6.94 | 2.01 | 8.53 | 0.2886 | 47.97 | 0.2771 | 11.77 | 147.35 | 11.20 | 13.61 | 10.33 |
| Varian Medical Systems, Inc. | 2.92bn | 357.70m | 10.56bn | 6.60k | 29.73 | 6.67 | 34.98 | 3.62 | 3.88 | 1.61 | 31.65 | 17.31 | 0.8921 | 3.85 | 2.93 | -- | 10.94 | 9.33 | 20.34 | 15.82 | 43.63 | 42.59 | 12.27 | 11.86 | 1.29 | 182.93 | 0.00 | -- | 11.45 | -0.1623 | 58.77 | -3.98 | -- | -- |
| DexCom, Inc. | 914.60m | 148.90m | 10.78bn | 2.29k | 72.00 | 19.16 | 62.08 | 11.78 | 1.68 | 0.4685 | 10.34 | 6.33 | 0.9346 | 6.50 | 6.53 | 399,388.70 | 15.22 | -7.96 | 18.10 | -10.11 | 65.01 | 67.45 | 16.28 | -5.67 | 4.43 | -- | 0.381 | -- | 25.33 | 48.38 | 184.60 | -- | 47.35 | -- |
| Hologic, Inc. | 3.22bn | -457.50m | 11.31bn | 6.23k | -- | 4.65 | 496.15 | 3.52 | -1.65 | -0.4172 | 11.61 | 8.93 | 0.4231 | 4.25 | 5.78 | -- | -6.02 | 1.97 | -7.66 | 2.29 | 52.73 | 52.70 | -14.22 | 5.42 | 0.9547 | 3.61 | 0.5764 | -- | 5.20 | 5.24 | -160.56 | -- | 3.23 | -- |
| Teleflex Incorporated | 2.40bn | 173.97m | 11.64bn | 14.40k | 67.11 | 4.64 | 30.67 | 4.84 | 3.77 | 1.41 | 52.16 | 54.55 | 0.4043 | 2.65 | 7.06 | 166,796.80 | 2.93 | 5.19 | 3.18 | 5.97 | 56.18 | 52.28 | 7.24 | 11.55 | 1.51 | 3.65 | 0.462 | 26.80 | 14.90 | 6.71 | 10.95 | -- | 1.63 | 0.00 |
| Cooper Companies Inc | 2.44bn | 324.50m | 12.62bn | 11.80k | 39.19 | 3.91 | 21.90 | 5.17 | 6.55 | 2.53 | 49.32 | 65.71 | 0.4426 | 1.90 | 6.87 | 207,017.00 | 5.88 | 6.96 | 6.36 | 7.82 | 63.68 | 62.20 | 13.28 | 15.44 | 1.54 | 6.51 | 0.4156 | 1.03 | 8.75 | 8.16 | 36.14 | 8.47 | 4.98 | 0.00 |
| Henry Schein, Inc. | 13.14bn | 537.33m | 13.15bn | 22.00k | 24.76 | 4.42 | 16.87 | 1.00 | 3.48 | 2.56 | 85.23 | 19.50 | 1.66 | 5.27 | 8.29 | 597,493.10 | 7.21 | 8.28 | 13.10 | 13.92 | 27.28 | 27.84 | 4.35 | 4.80 | 0.7001 | 16.81 | 0.3684 | 0.00 | 7.69 | 6.87 | 8.38 | 7.19 | 9.73 | -- |
| ABIOMED, Inc. | 690.25m | 211.89m | 13.50bn | 1.14k | 65.26 | 17.03 | 60.31 | 19.56 | 4.59 | 4.13 | 14.97 | 17.61 | 0.8727 | 2.22 | 10.50 | 603,889.80 | 26.79 | 17.28 | 29.50 | 19.66 | 83.23 | 83.34 | 30.70 | 19.35 | 6.07 | -- | 0.00 | 0.00 | 33.34 | 30.29 | 156.29 | 54.83 | 81.50 | -- |
| ResMed Inc. | 2.40bn | 473.73m | 14.62bn | 5.94k | 31.18 | 7.69 | 24.58 | 6.08 | 3.29 | 2.33 | 16.70 | 13.34 | 0.7335 | 3.45 | 5.30 | 404,851.20 | 14.45 | 13.28 | 16.38 | 15.61 | 58.20 | 59.41 | 19.70 | 19.48 | 1.91 | 44.53 | 0.218 | 46.18 | 13.23 | 9.09 | 32.52 | 8.11 | -0.0907 | 15.54 |
| Align Technology, Inc. | 1.85bn | 372.21m | 16.35bn | 8.72k | 44.83 | 13.71 | 38.36 | 8.82 | 4.56 | 3.84 | 22.71 | 14.92 | 1.02 | 10.98 | 5.00 | 212,713.10 | 20.80 | 15.31 | 29.62 | 20.04 | 74.59 | 75.69 | 20.34 | 17.93 | 1.90 | -- | 0.00 | 0.00 | 36.44 | 21.34 | 66.45 | 40.01 | 38.55 | -- |
| IDEXX Laboratories, Inc. | 2.17bn | 360.65m | 16.69bn | 7.60k | 47.61 | -- | 37.52 | 7.69 | 4.06 | 3.72 | 24.45 | -0.0185 | 1.35 | 5.37 | 8.68 | 285,523.30 | 22.44 | 15.34 | 49.50 | 33.36 | 55.93 | 55.25 | 16.62 | 13.13 | 0.6906 | 14.18 | 1.00 | 0.00 | 10.91 | 8.77 | 32.47 | 10.53 | 5.56 | -- |
| Zimmer Biomet Holdings Inc | 7.94bn | 480.90m | 23.15bn | 18.20k | 48.36 | 1.90 | 15.11 | 2.92 | 2.35 | 8.58 | 38.78 | 59.89 | 0.3064 | 1.08 | 6.15 | 436,054.90 | 1.86 | 2.75 | 2.08 | 3.02 | 70.85 | 71.34 | 6.07 | 8.08 | 0.9593 | 6.00 | 0.4294 | 33.44 | 1.82 | 11.84 | 76.99 | -6.43 | 13.26 | 5.92 |
Data as of Nov 20 2018. Currency figures normalised to Align Technology Inc's reporting currency: US Dollar USD
34.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2018 | 7.91m | 9.85% |
| BlackRock Fund Advisorsas of 30 Sep 2018 | 3.77m | 4.69% |
| SSgA Funds Management, Inc.as of 30 Sep 2018 | 3.01m | 3.75% |
| Sands Capital Management LLCas of 30 Sep 2018 | 2.84m | 3.54% |
| Renaissance Technologies LLCas of 30 Sep 2018 | 2.78m | 3.46% |
| Polen Capital Management LLCas of 30 Sep 2018 | 2.11m | 2.63% |
| Fidelity Management & Research Co.as of 30 Sep 2018 | 1.76m | 2.19% |
| Invesco Capital Management LLCas of 30 Sep 2018 | 1.09m | 1.36% |
| Geode Capital Management LLCas of 30 Sep 2018 | 1.05m | 1.31% |
| T. Rowe Price Associates, Inc.as of 30 Sep 2018 | 1.01m | 1.26% |
More ▼
Data from 30 Sep 2018 - 30 Sep 2018Source: FactSet Research Systems Inc.
